Literature DB >> 2582257

Inflammatory mediators in late antigen-induced rhinitis.

R M Naclerio, D Proud, A G Togias, N F Adkinson, D A Meyers, A Kagey-Sobotka, M Plaut, P S Norman, L M Lichtenstein.   

Abstract

To investigate the mechanisms responsible for the late-phase response in patients with allergies, we measured four biochemical mediators (histamine, tosyl-L-arginine methyl ester [TAME]-esterase, kinin, and prostaglandin D2) in nasal secretions after nasal challenge with pollen antigen in 12 patients with allergy. Nine patients had an immediate response and a recurrence of symptoms 3 to 11 hours after challenge. The clinical symptoms during recurrence were accompanied by a second increase in levels of histamine, TAME--esterase, and kinin over base-line values, although kinin levels were lower than during the immediate response. In contrast, although the levels of prostaglandin D2 were significantly increased during the immediate response, they did not increase above base line during the late response. Rechallenge with allergen 11 hours after the initial provocation, however, was associated with reappearance of all four biochemical mediators, including prostaglandin D2. We conclude that the late response to nasal challenge with allergen is accompanied by a second increase in the concentrations of histamine and TAME--esterase but differs from the immediate response in the lack of prostaglandin D2 production and in the amount of kinin generated. Since histamine is released only by mast cells and basophils and prostaglandin D2 is not produced by basophils, we suggest that these cells are partly responsible for the late-phase response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582257     DOI: 10.1056/NEJM198507113130201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  70 in total

Review 1.  Basophils in airway disease.

Authors:  Donald MacGlashan; Gail Gauvreau; John T Schroeder
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

Review 2.  Immunotherapy for mold allergy.

Authors:  H J Malling
Journal:  Clin Rev Allergy       Date:  1992

Review 3.  The pharmacology of airway hyperresponsiveness and inflammation.

Authors:  R Pauwels
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Reversibility and reproducibility of histamine induced plasma leakage in nasal airways.

Authors:  C Svensson; C R Baumgarten; U Pipkorn; U Alkner; C G Persson
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

Review 5.  Leukocyte activation following IgE dependent mechanisms in bronchial asthma.

Authors:  S R Durham
Journal:  Clin Rev Allergy       Date:  1989

6.  A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin.

Authors:  J A Pongracic; R M Naclerio; C J Reynolds; D Proud
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

7.  Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin.

Authors:  Chieko Shimura; Takahiro Satoh; Ken Igawa; Kosuke Aritake; Yoshihiro Urade; Masataka Nakamura; Hiroo Yokozeki
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma.

Authors:  N Crimi; R Polosa; G Pulvirenti; S Magrì; G Santonocito; G Prosperini; C Mastruzzo; A Mistretta
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

Review 9.  Allergic rhinitis in children : diagnosis and management strategies.

Authors:  William E Berger
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

10.  Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.

Authors:  John A Eckman; Patricia M Sterba; Denise Kelly; Val Alexander; Mark C Liu; Bruce S Bochner; Donald W Macglashan; Sarbjit S Saini
Journal:  J Allergy Clin Immunol       Date:  2009-12-04       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.